NASDAQ:PROG

Biora Therapeutics, Inc.

Stock

USD

Last Close

0.92

09/05 04:00

Market Cap

8.18M

Beta: -

Volume Today

2.78M

Avg: 6.37M

PE Ratio

−0.11

PFCF: −0.53

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-129.11M -	-148.04M 14.66%	-192.53M 30.05%	-178.52M 7.28%	-38.16M 78.63%	-124.11M 225.27%
depreciation and amortization	6.07M -	6.35M 4.54%	5.06M 20.32%	1.44M 71.60%	907K 36.88%	555K 38.81%
deferred income tax	6.25M -		58.57M -	21.93M 62.56%
stock based compensation	2.26M -	2.38M 4.95%	10.67M 349.18%	11.96M 12.13%	7.80M 34.76%	16.48M 111.11%
change in working capital	46.16M -	32.65M 29.26%	-51.17M 256.70%	-25.86M 49.45%	-4.65M 82.02%	-1.17M 74.80%
accounts receivables	584K -	3.43M 487.16%	9.51M 177.28%		-828K -
inventory	-3.48M -	-3.86M 10.99%	-1.43M 63.05%		828K -
accounts payables	5.77M -	4.38M 24.04%	2.86M 34.82%	-8.69M 404.03%	-5.07M 41.61%	-1.17M 76.89%
other working capital	43.28M -	28.70M 33.69%	-62.11M 316.42%	-17.18M 72.34%	422K 102.46%	1.17M 177.73%
other non cash items	3.24M -	535K 83.48%	3.66M 583.36%	1.57M 57.00%	-30.32M 2,028.82%	58.59M 293.22%
net cash provided by operating activities	-65.13M -	-106.12M 62.95%	-165.74M 56.18%	-167.49M 1.05%	-64.42M 61.54%	-48.50M 24.71%
investments in property plant and equipment	-4.83M -	-3.73M 22.91%	-4.94M 32.72%	-855K 82.71%	-792K 7.37%	-103K 86.99%
acquisitions net		50K -
purchases of investments	-167.01M -	-11.21M 93.29%
sales maturities of investments	227.67M -	31.41M 86.20%
other investing activites				-387K -		11K -
net cash used for investing activites	55.83M -	16.52M 70.40%	-4.94M 129.92%	-1.24M 74.88%	-792K 36.23%	-92K 88.38%
debt repayment	-1.75M -	-1.27M 27.14%	-983K 22.90%	-1.64M 67.14%	-12K 99.27%
common stock issued	459K -	551K 20.04%	116.44M 21,031.58%	46.78M 59.83%	9.01M 80.73%	18.14M 101.21%
common stock repurchased	-11.27M -	79.04M 801.57%			98K -
dividends paid		-4.50M -
other financing activites	-250K -	-179K 28.40%	114.27M 63,937.99%	119.92M 4.94%	-1.80M 101.50%	12.64M 801.66%
net cash used provided by financing activities	-12.81M -	73.64M 674.97%	229.72M 211.97%	165.05M 28.15%	7.30M 95.58%	30.78M 321.77%
effect of forex changes on cash	9.29M -					2.54M -
net change in cash	-22.10M -	-15.96M 27.78%	59.03M 469.82%	-3.68M 106.23%	-57.91M 1,474.10%	-15.28M 73.62%
cash at beginning of period	71.11M -	49.01M 31.08%	33.04M 32.57%	92.08M 178.66%	88.40M 4.00%	30.49M 65.51%
cash at end of period	49.01M -	33.04M 32.57%	92.08M 178.66%	88.40M 4.00%	30.49M 65.51%	15.21M 50.10%
operating cash flow	-65.13M -	-106.12M 62.95%	-165.74M 56.18%	-167.49M 1.05%	-64.42M 61.54%	-48.50M 24.71%
capital expenditure	-4.83M -	-3.73M 22.91%	-4.94M 32.72%	-855K 82.71%	-792K 7.37%	-103K 86.99%
free cash flow	-69.96M -	-109.85M 57.02%	-170.69M 55.38%	-168.34M 1.38%	-65.21M 61.26%	-48.60M 25.47%

All numbers in USD (except ratios and percentages)